264 related articles for article (PubMed ID: 14266922)
1. AFRICAN HORSE-SICKNESS LIVE-VIRUS TISSUE CULTURE VACCINE.
OZAWA Y; HAZRATI A; EROL N
Am J Vet Res; 1965 Jan; 26():154-68. PubMed ID: 14266922
[No Abstract] [Full Text] [Related]
2. GROWTH OF AFRICAN HORSE-SICKNESS VIRUS IN MONKEY KIDNEY CELL CULTURES.
OZAWA Y; HAZRATI A
Am J Vet Res; 1964 Mar; 25():505-11. PubMed ID: 14125925
[No Abstract] [Full Text] [Related]
3. SEROLOGIC STUDIES OF AFRICAN HORSE-SICKNESS VIRUS WITH EMPHASIS ON NEUTRALIZATION TEST IN TISSUE CULTURE.
HAZRATI A; OZAWA Y
Can J Comp Med Vet Sci; 1965 Jul; 29(7):173-8. PubMed ID: 14300857
[TBL] [Abstract][Full Text] [Related]
4. Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination.
Manning NM; Bachanek-Bankowska K; Mertens PPC; Castillo-Olivares J
Vaccine; 2017 Oct; 35(44):6024-6029. PubMed ID: 28438410
[TBL] [Abstract][Full Text] [Related]
5. African horse-sickness killed-virus tissue culture vaccine.
Ozawa Y; Bahrami S
Can J Comp Med Vet Sci; 1966 Nov; 30(11):311-4. PubMed ID: 4226381
[TBL] [Abstract][Full Text] [Related]
6. Immunization against equine viral arteritis using modified live virus propagated in cell cultures of rabbit kidney.
Doll ER; Bryans JT; Wilson JC; McCollum WH
Cornell Vet; 1968 Oct; 48(4):497-524. PubMed ID: 4971878
[No Abstract] [Full Text] [Related]
7. VP2 Exchange and NS3/NS3a Deletion in African Horse Sickness Virus (AHSV) in Development of Disabled Infectious Single Animal Vaccine Candidates for AHSV.
van de Water SG; van Gennip RG; Potgieter CA; Wright IM; van Rijn PA
J Virol; 2015 Sep; 89(17):8764-72. PubMed ID: 26063433
[TBL] [Abstract][Full Text] [Related]
8. AN ATTENUATED MUTANT OF JAPANESE ENCEPHALITIS VIRUS.
INOUE YK
Bull World Health Organ; 1964; 30(2):181-5. PubMed ID: 14153407
[TBL] [Abstract][Full Text] [Related]
9. Inactivated African horse sickness virus cell culture vaccine.
Mirchamsy H; Taslimi H
Immunology; 1968 Jan; 14(1):81-8. PubMed ID: 5635756
[TBL] [Abstract][Full Text] [Related]
10. Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus.
Guthrie AJ; Quan M; Lourens CW; Audonnet JC; Minke JM; Yao J; He L; Nordgren R; Gardner IA; Maclachlan NJ
Vaccine; 2009 Jul; 27(33):4434-8. PubMed ID: 19490959
[TBL] [Abstract][Full Text] [Related]
11. Serological response of foals to polyvalent and monovalent live-attenuated African horse sickness virus vaccines.
Crafford JE; Lourens CW; Smit TK; Gardner IA; MacLachlan NJ; Guthrie AJ
Vaccine; 2014 Jun; 32(29):3611-6. PubMed ID: 24814557
[TBL] [Abstract][Full Text] [Related]
12. Thermal stability of African horse sickness virus.
Mirchamsy H; Taslimi H
Arch Gesamte Virusforsch; 1967; 20(2):275-7. PubMed ID: 4970516
[No Abstract] [Full Text] [Related]
13. African horse sickness virus (AHSV) with a deletion of 77 amino acids in NS3/NS3a protein is not virulent and a safe promising AHS Disabled Infectious Single Animal (DISA) vaccine platform.
van Rijn PA; Maris-Veldhuis MA; Potgieter CA; van Gennip RGP
Vaccine; 2018 Apr; 36(15):1925-1933. PubMed ID: 29525278
[TBL] [Abstract][Full Text] [Related]
14. Interference between African horse-sickness viruses in tissue culture.
Ozawa Y
Zahnarztl Prax; 1966 Jan; 17(2):106-9. PubMed ID: 4958274
[No Abstract] [Full Text] [Related]
15. VISUALIZATION OF HORSE SICKNESS VIRUS BY THE FLUORESCENT ANTIBODY TECHNIQUE.
MIRCHAMSY H; TASLIMI H
Immunology; 1964 May; 7(3):213-6. PubMed ID: 14169105
[TBL] [Abstract][Full Text] [Related]
16. Serological responses of horses immunized with live attenuated African horse sickness vaccine.
Mirchamsy H; Taslimi H
J Comp Pathol; 1967 Oct; 77(4):431-8. PubMed ID: 4295721
[No Abstract] [Full Text] [Related]
17. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINES. II. SV 40 IN INACTIVATED POLIOMYELITIS VACCINES].
GUENTHER O; HOEVEL H; VON METTENHEIM
Zentralbl Bakteriol Orig; 1963 Dec; 190():445-65. PubMed ID: 14166424
[No Abstract] [Full Text] [Related]
18. Development of a modified virus strain and vaccine for equine viral arteritis.
McCollum WH
J Am Vet Med Assoc; 1969 Jul; 155(2):318-22. PubMed ID: 4978804
[No Abstract] [Full Text] [Related]
19. [ULTRASTRUCTURAL STUDY OF THE DEVELOPMENT OF A LATENT SIMIAN VIRUS].
GRANBOULAN N; WICKER R
C R Hebd Seances Acad Sci; 1963 Jul; 257():1194-6. PubMed ID: 14054219
[No Abstract] [Full Text] [Related]
20. CULTIVATION OF HORSESICKNESS VIRUS IN TISSUE CULTURE.
ERASMUS BJ
Nature; 1963 Nov; 200():716. PubMed ID: 14109987
[No Abstract] [Full Text] [Related]
[Next] [New Search]
